Diabetes and obesity drugs reduce COVID-19 complications, analysis shows
By
Alicia Lasek
Sep 28, 2021
Diabetes type 2 is linked to severe COVID-19 illness, but a type of drug used to improve glycemic control and weight loss may also reduce complications from the viral disease, a new study finds.
Donepezil may help preserve muscle cell functioning in Alzheimer’s
By
Alicia Lasek
Sep 28, 2021
People with early Alzheimer’s who are treated with the drug donepezil maintain mitochondrial function in their muscles when compared to their untreated peers, researchers report.
Treat nighttime BP swings to cut diabetes mortality risk, 21-year study suggests
By
Alicia Lasek
Sep 28, 2021
Abnormal nighttime blood pressure dips can double the odds of death for patients with diabetes, a long-term study has found. Clinicians should regularly look for and treat the problem, investigators say.
Clinical briefs for Tuesday, Sept. 28
By
Alicia Lasek
Sep 28, 2021
Unvaccinated nursing home workers in New York could be replaced by National Guard … Diabetic foot ulcers program in Belgium kept wounds under control during COVID lockdown … Oral anti-diabetic...
Booster clinics set to begin in facilities following CDC sign-off on Pfizer shot
By
Danielle Brown
Sep 27, 2021
Booster shot clinics at long-term care facilities are expected to begin immediately after the Centers for Disease Control and Prevention on Friday recommended that Pfizer’s COVID-19 booster dose be administered...
Nursing homes ended 2020 with nearly 8% decline in occupancy rate: NIC
By
Danielle Brown
Sep 27, 2021
The COVID-19 pandemic caused the skilled nursing occupancy rate to drop by about 7.7% between 2019 and 2020, according to a new report by the National Investment Center for Seniors Housing & Care.
What in the name of God is going on?
By
John O'Connor
Sep 27, 2021
Seems like a lot of people are finding religion these days. Or to be more accurate, their “sincerely held religious beliefs.”
COVID-19 antiviral drug trials expected to wrap up within months: report
By
Alicia Lasek
Sep 27, 2021
Clinical trials for new COVID-19 antiviral drugs are expected to wrap up by winter, sparking hopes that a daily pill to treat COVID-19 infection is closer to fruition, according to a new report.
‘Another layer of protection’: Senior care industry commends feds’ booster vaccine decision
By
Alicia Lasek
Sep 27, 2021
Industry advocates are welcoming the decision to include residents of long-term care settings and healthcare workers in a new federal recommendation to offer COVID-19 booster shots to at-risk adults.
WHO: Antibody treatment most beneficial for seniors, the unvaccinated, and immunocompromised
By
Alicia Lasek
Sep 27, 2021
The World Health Organization’s new guidance for using the REGEN-COV monoclonal antibody cocktail to treat COVID-19 covers a narrower group of patients than those included in the FDA’s updated...